Viewing StudyNCT00282295



Ignite Creation Date: 2024-05-05 @ 4:38 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00282295
Status: COMPLETED
Last Update Posted: 2018-08-17
First Post: 2006-01-25

Brief Title: US-licensed Combined Vaccine Against Tetanus Diphtheria Given With US-licensed Vaccine Against Meningococcal Disease
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Organization Data

Organization: GlaxoSmithKline
Class: INDUSTRY
Study ID: 105753
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: GlaxoSmithKline
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators